Login / Signup

S-acylation regulates the trafficking and stability of the unconventional Q-SNARE STX19.

Khamal K AmpahJennifer GreavesAmber S Shun-ShionAsral W AsnawiJessica A LidsterLuke H ChamberlainMark O CollinsAndrew A Peden
Published in: Journal of cell science (2018)
STX19 is an unusual Qa-SNARE as it lacks a C-terminal transmembrane domain. However, it is efficiently targeted to post-Golgi membranes. Here, we set out to determine the intracellular localisation of endogenous STX19 and elucidate the mechanism by which it is targeted to membranes. We have found that a pool of STX19 is localised to tubular recycling endosomes where it colocalises with MICAL-L1 and Rab8 (which has Rab8a and Rab8b forms). Using a combination of genetic, biochemical and cell-based approaches, we have identified that STX19 is S-acylated at its C-terminus and is a substrate for several Golgi-localised S-acyltransferases, suggesting that STX19 is initially S-acylated at the Golgi before trafficking to the plasma membrane and endosomes. Surprisingly, we have found that S-acylation is a key determinant in targeting STX19 to tubular recycling endosomes, suggesting that S-acylation may play a general role in directing proteins to this compartment. In addition, S-acylation also protects STX19 from proteosomal degradation, indicating that S-acylation regulates the function of STX19 at multiple levels.This article has an associated First Person interview with the first author of the paper.
Keyphrases
  • cancer therapy
  • endoplasmic reticulum
  • mesenchymal stem cells
  • genome wide
  • endothelial cells
  • high glucose
  • amino acid